IIFL Securities Ltd Q2 FY27 Results

IIFL Capital's Q2 result lands on a transitional footing. In Q1 FY27, the company posted ₹631 Cr consolidated operating revenue and ₹184 Cr net profit—steady core earnings masked by a strong institutional broking and investment banking push (up 27% QoQ). The wealth management franchise continues to scale with 400+ Relationship Managers and traction in AUM and financial product distribution (FPD). The real headline, though, is the Fairfax takeover: FIH Mauritius secured CCI approval on September 22 for a 26% open offer at ₹350/share, on track to reach 51% control once combined with existing HWIC Asia Fund holding. Management flagged that completion is expected within 2–3 months—putting a potential capital infusion and board transition within reach by year-end. Q2 will reveal whether the institutional momentum sustained and how management positioned the business ahead of the control shift.

A strong Q2 would show IB momentum holding, wealth AUM growing, and net profit in the ₹185–195 Cr range—evidence that the business can scale ahead of a Fairfax restructure. A weak print would be flat or contracting IB revenue, AUM stalling, and profit falling below ₹175 Cr—signaling client jitter or capital strain as the takeover drags on. The most likely case is steady-state: revenue in the mid-₹630s, profit ₹180s, and the Street using it as a data point on how much Fairfax capital injection can accelerate the game.

The penalty cluster is material in headline terms but appears manageable if pass-through holds. The CRO departure is more structural—it signals either a disagreement on risk posture or a natural transition ahead of Fairfax's governance reshape. Neither is catastrophic, but Q2 messaging on compliance roadmap and CRO search will matter to the Street.

1. Institutional broking & IB: did the 27% QoQ surge stick? If it stalled, the narrative flips to cyclical headwind. If it held or grew, it validates management's confidence in the capital-markets franchise as a Fairfax growth pillar. Watch for deal pipeline color and advising AUM. 2. Wealth & AUM: is the slowdown over? Management promised an acceleration post-Q2. Q2 AUM net addition and RM productivity trends will set tone for H2 expectations. This is the crown jewel Fairfax wants to scale. 3. Penalty and CRO fallout: any P&L hit or governance commentary? Probe whether penalties are truly pass-through and get management's timeline on filling the CRO role. Fairfax's presence in the call may also signal how imminent the control shift feels.

IIFL Capital Services (formerly IIFL Securities) posted consolidated PAT of ₹126.61 Cr for Q2 FY27, up 48.7% YoY from ₹85.15 Cr but down 31.3% QoQ from ₹184.16 Cr. Consolidated revenue from operations was ₹714.40 Cr, up 24.9% YoY and 13.1% QoQ. Basic EPS was ₹4.07 versus ₹2.72 a year ago and ₹5.92 last quarter. Standalone PAT was ₹122.12 Cr, up 33.7% YoY — a materially slower rate than the consolidated 48.7%, so the two bases tell a somewhat different growth story this quarter, with subsidiaries (facilities and insurance-broking segments) adding the incremental gain at the group level.

The YoY-vs-QoQ split is explained almost entirely by the "other income" line, not the core franchise: fee & commission income and interest income both grew comfortably sequentially, but other income flipped from a ₹89.83 Cr gain in Q1 FY27 to a ₹24.07 Cr loss this quarter — a roughly ₹114 Cr swing that pulled PBT down from ₹239.28 Cr to ₹174.26 Cr QoQ. Strip that volatility out and profitability actually improved YoY: net margin (PAT/total income) expanded to 18.3% from 15.6% a year ago, and PBT/revenue-from-operations rose to 24.4% from 21.0%, even though both are well below last quarter's other-income-inflated 25.5%/37.9%.

The stock went into the print at ₹346, down 0.3% over the past month of trading.

Against our pre-result preview (consolidated revenue ~₹620-650 Cr, net profit ~₹175-190 Cr), the quarter beat on revenue (₹714 Cr) but missed meaningfully on profit (₹126.6 Cr) — no independent Q2 FY27 consensus estimate for this company turned up in search, so the preview band is the best available yardstick, and the shortfall traces to the other-income reversal rather than the broking/wealth business. Management gave no quantitative FY27 guidance on the last call, only a multi-year "~20% growth" aspiration that this quarter's 24.9% YoY revenue growth is tracking at or above. The bigger guidance item — Fairfax's regulatory approval, targeted "within 2-3 months" of the July 30, 2026 call — has now been met: the filing confirms all requisite regulatory and shareholder approvals for FIH Mauritius/Fairfax's up to 51% stake have been received, with the preferential allotment and open offer under implementation (the ~₹2,000 Cr at ₹350/share has not yet landed). This resolves the CCI-approval watch item flagged in our pre-result preview. The quarter also carried a cluster of regulatory penalties (SEBI twice for ₹2 lakh each, MCX ₹28.1 lakh and ₹2.05 lakh, BSE ₹51.26 lakh — about ₹85 lakh combined) and the Chief Risk Officer's October 15 resignation; both are financially immaterial against ₹126.6 Cr PAT but are governance datapoints alongside the parallel Board move to re-designate Vasudev Jagannath as Managing Director effective January 1, 2027. No management press release was available for this filing, so framing rests on the results statement and notes alone.

IIFL posted 24.9% YoY revenue growth powered by strong institutional broking and FPD distribution, with Fairfax's ₹2,000 Cr capital infusion due November 2026 opening a long-term wealth/lending platform. However, PAT collapsed 31.3% QoQ despite revenue growth, margins compressed, and finance costs surge 40% YoY as leverage rises—offsetting operational gains. Wealth business remains unprofitable (break-even targeted 6–18 months), insurance revenue is declining, and macro headwinds (geopolitical, forex) add near-term drag.

Analysts pressed on wealth business losses, PMS AUM declines, insurance underperformance, and QoQ margin collapse. Management was evasive on numbers ('I'll call you separately'), acknowledged headwinds but did not quantify near-term profit pressure. No hard pushback on Fairfax or succession; market accepted both.

Score 6/10. Cautious and macro-aware; transparent on macro headwinds and regulatory timelines. Evasive on wealth business losses and PMS outflows until pressed; deferred on exact Fairfax deployment details. Met multi-year ~20% growth guidance; delivered 24.9% YoY revenue Q2 FY27. Institutional broking momentum validated. Wealth platform and insurance underperformance extend timeline, weakening prior execution credibility.